Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. The company’s first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Our long-term focus is on additional areas in women’s health that include symptoms of menopause, reproductive disorders, and frailty associated with aging. Radius’ scientific leadership includes some of the world’s leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.